IRVINE, Calif., Aug. 21, 2017 -- Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Tableau Software, Inc. (“Tableau” or the “Company”) (NYSE:DATA). Investors who purchased or otherwise acquired shares from June 3, 2015 through February 4, 2016, inclusive (the “Class Period”), are encouraged to contact the Firm before the September 26, 2017 lead plaintiff motion deadline.
If you purchased Tableau shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at [email protected].
There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.
According to the Complaint, throughout the Class Period, Tableau made false and/or misleading statements, and/or failed to disclose, that product launches and upgrades by major software competitors were negatively impacting the Company’s competitive position and profitability. As a result, Tableau’s financial statements were materially false and misleading at all relevant times. On August 7, 2015, the Company filed a quarterly report on Form 10-Q reaffirming financial results issued in a July 29, 2015 press release. On February 4, 2016, the Company disclosed slowing revenue. In a related earnings call, the Chief Executive Officer stated that “the competitive dynamic has become more crowded and difficult.” Upon release of this news, Tableau’s stock price dropped materially, which caused investors harm according to the Complaint.
If you wish to learn more about this lawsuit, or if you have any questions regarding this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for almost two decades, by telephone at (949) 419-3834, or by e-mail at [email protected].
This press release may constitute Attorney Advertising in certain jurisdictions.
Contact Joon M. Khang, Esq. Telephone: 949-419-3834 Facsimile: 949-225-4474 [email protected]


Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Washington Post Publisher Will Lewis Steps Down After Layoffs
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 



